Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

This study observed that adherence to finasteride treatment in patients with benign prostatic hyperplasia at a clinic in Tepic Nayarit had not been previously evaluated in Mexico.

This study examined alopecia coding trends using the American Academy of Dermatology's DataDerm registry, aiming to assess the impact of evaluation and management CPT coding updates pre- and post-2021 on reimbursement and visit complexity. Results were not reported in the abstract.

This study found that using a PEG-400/oleic acid mixture as an optical clearing agent enhanced the detection depth of particles in skin without causing dehydration, based on tests in rats and further testing in vivo.

This study found that patients with psoriasis have a significantly higher prevalence of autoimmune diseases and other physical and mental comorbidities compared to those without the condition.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

This review assessed the clinical and cost-effectiveness of baricitinib, an oral treatment for severe alopecia areata in adults, to inform Canadian reimbursement recommendations, excluding Quebec.

Clear definitions and strategies are needed to manage long-term COVID-19 symptoms effectively.

This study developed a sensitive HPLC-MS/MS method for determining cyproterone acetate levels in human plasma and found no significant difference in its concentration between two oral formulations in bioequivalence testing.

In this study, researchers found that complementary and alternative medicine remains widely used by Korean patients with psoriasis despite advances in biologic treatments, highlighting the need for better education on conventional therapies.

This editorial reviews recent European legal developments related to patents on second medical uses and dosage regimes, with no new research findings reported.

Patients follow treatment well, but many change medicines; good information helps compliance.

This study found that paclitaxel poliglumex induces significantly less and milder alopecia compared with standard taxanes in ovarian and breast cancer patients.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

This review discusses personalized treatment strategies and management approaches for chronic obstructive pulmonary disease (COPD), emphasizing the need for multi-aspect assessments, but reports no new clinical findings.

The researchers concluded that after the 2013 EMA recommendation, there was an overall reduction in CPA/EE prescriptions, but no substantial change in patient diagnoses or potential concurrent hormonal contraceptive use.

This study found that a substantial number of patients continued tamsulosin and/or finasteride unnecessarily after prostate surgery, with poor documentation and communication contributing to this issue.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

This article discusses the critical role of pharmacists in counseling Portuguese patients with hair loss, emphasizing education about treatment options and the importance of addressing the associated emotional burden.

This study developed the Alopecia Areata Patient Priority Outcome (AAPPO), a new tool designed to measure and capture the symptoms and impacts of alopecia areata that matter most to patients.

In this study, researchers analyzed data from Spain to find that alopecia areata is more prevalent in adults, with a point prevalence of 0.44% in 2021; they also noted significant healthcare costs and comorbidities, highlighting an unmet treatment need given limited systemic treatment use.

This review discusses several new pharmacological products, including those for cardiovascular prevention and overactive bladder, but notes challenges in defining their therapeutic roles and provides safety updates on existing medications; it reports no new clinical results.

In this study, Norwegian researchers followed over 350 patients with porphyria cutanea tarda for an average of 7 years and found that 25% experienced biochemical relapse, suggesting the importance of routine follow-up for early detection and management.

This study observed that most women with PCOS in the United States use adaptive coping strategies, while those with higher psychological severity may resort to maladaptive coping methods.

This study found that among Korean patients with pattern hair loss, the subjective severity of hair loss and socio-psychological stress influenced their expenditure and quality of life, rather than the clinical severity.